Imagine human
health through
a new collective
intelligence

Imagine…

a world where most diseases can be cured. Imagine the way in which biological and medical research interplay: pharmaceutical industry, biotech companies, physicians and scientists sharing their skills and discoveries for the benefit of universal human health. Imagine people contributing to medical advancement by populating a single and unique platform with their own medical records. Imagine an artificial intelligence platform that could bring a breakthrough in medical research. Imagine human health through this new collective intelligence.

This is not a utopic world.
This is TOPAZIUM. Smart medicine.

ACCESS
AI PLATFORM

Our philosophy

The enjoyment of the highest attainable standard of health

“Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. The enjoyment of the highest attainable standard of health is one of the fundamental rights of every human being and is dependent on the fullest co-operation of individuals and States”

Constitution of the World Health Organization, 1946

“An acceptable level of health for all the people of the world can be attained through a fuller and better use of the world’s resources”

Declaration of Alma-Ata – International Conference on Primary Health Care, 1978

 

“It is far more important to know what person the disease has than what disease the person has”

Hippocrates

SERVICES

We provide artificial intelligence services to all players in the healthcare arena, including academic institutions, hospitals, pharmaceutical companies and biotech companies. These services include data processing, encoding and access to advanced deep learning solutions for:

Identification of pathophysiological processes that drive certain diseases.
Discovery and classification of new chemical entites.
Prediction of specific target-binding affinities or drug-like properties.
Identification of chemical structures associated to certain toxic effects.
Prediction of unexpected human toxicity.
Selection of drug candidates for clinical trials.
Early identification of subpopulations at a higher risk of certain diseases.
Matching drugs no longer used with new clinical indications.
Prediction of “super-response” to specific drugs.
Monitoring quality of life and lifestyle changes.

Our pipeline

TOPAZIUM is engaged with continuous innovation in several healthcare areas

News & Publications

View all >

Partners
& Clients